These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM; Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996 [TBL] [Abstract][Full Text] [Related]
15. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Hamed SA Expert Rev Clin Pharmacol; 2019 Jan; 12(1):61-90. PubMed ID: 30501441 [No Abstract] [Full Text] [Related]
16. Does Chronic Kidney Disease Have an Impact on the Use of Oral Anticoagulants after Stroke? An Observational Follow-Up Study. Laible M; Horstmann S; Ringleb PA; Veltkamp R; Jenetzky E; Rizos T Eur Neurol; 2021; 84(5):354-360. PubMed ID: 34167122 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, thrombolytic management, and outcomes of acute stroke among patients with chronic kidney disease: a systematic review and meta-analysis. Zamberg I; Assouline-Reinmann M; Carrera E; Sood MM; Sozio SM; Martin PY; Mavrakanas TA Nephrol Dial Transplant; 2022 Jun; 37(7):1289-1301. PubMed ID: 34100934 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy for preventing stroke in patients with chronic kidney disease. Kim SJ; Bang OY Contrib Nephrol; 2013; 179():119-29. PubMed ID: 23652455 [TBL] [Abstract][Full Text] [Related]